Envestnet Asset Management Inc. Has $19.47 Million Stock Position in Humana Inc. $HUM

Envestnet Asset Management Inc. lowered its position in shares of Humana Inc. (NYSE:HUM) by 26.1% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 74,821 shares of the insurance provider’s stock after selling 26,481 shares during the quarter. Envestnet Asset Management Inc. owned approximately 0.06% of Humana worth $19,466,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Elevation Point Wealth Partners LLC bought a new stake in Humana during the 2nd quarter worth about $32,000. Mather Group LLC. acquired a new stake in shares of Humana during the 3rd quarter worth approximately $34,000. AlphaCore Capital LLC bought a new stake in shares of Humana during the second quarter worth approximately $39,000. Private Wealth Management Group LLC raised its stake in shares of Humana by 47.5% during the third quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock worth $39,000 after buying an additional 48 shares during the last quarter. Finally, SJS Investment Consulting Inc. lifted its holdings in Humana by 19,300.0% in the third quarter. SJS Investment Consulting Inc. now owns 194 shares of the insurance provider’s stock valued at $50,000 after buying an additional 193 shares during the period. Institutional investors own 92.38% of the company’s stock.

Humana Stock Performance

Shares of Humana stock opened at $183.92 on Friday. The stock’s fifty day simple moving average is $244.65 and its 200 day simple moving average is $261.05. The company has a current ratio of 2.00, a quick ratio of 2.02 and a debt-to-equity ratio of 0.70. The company has a market capitalization of $22.12 billion, a PE ratio of 18.73, a PEG ratio of 2.04 and a beta of 0.44. Humana Inc. has a 12 month low of $169.61 and a 12 month high of $315.35.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($4.01) by $0.05. The firm had revenue of $32.64 billion during the quarter, compared to analysts’ expectations of $32.08 billion. Humana had a return on equity of 11.43% and a net margin of 0.92%.The company’s revenue was up 11.3% on a year-over-year basis. During the same period in the previous year, the firm earned ($2.16) earnings per share. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. On average, research analysts predict that Humana Inc. will post 16.47 EPS for the current year.

Trending Headlines about Humana

Here are the key news stories impacting Humana this week:

• Positive Sentiment: CenterWell (Humana’s healthcare services unit) closed the acquisition of MaxHealth, adding a sizable Florida primary‑care network (~82 owned/affiliated clinics and >80,000 patients in value‑based programs) which expands Humana’s senior-focused, value‑based primary care footprint and accelerates revenue and membership growth in higher-value care. CenterWell Completes Acquisition of MaxHealth
• Positive Sentiment: Management signals more primary‑care deals may be coming (CEO remarks and media reports about a potential ~$1B strategic push), reinforcing the company’s strategy to grow value‑based care capacity — a long‑term growth catalyst if Humana can scale clinics and convert MA members to higher‑margin care. Humana CEO hints at upcoming primary care deal
• Neutral Sentiment: Jefferies cut its price target (from $310 to $235) but kept a Buy rating, reflecting disagreement among analysts on Humana’s growth vs. margin tradeoff — some firms still see upside despite lower near‑term earnings visibility. Jefferies price target change
• Negative Sentiment: Several major analysts materially lowered price targets and trimmed estimates (TD Cowen to $173 Hold; JPMorgan to $180 Neutral; Evercore, Cantor, Leerink also cut targets), reflecting concern that Medicare Advantage cost pressures, lower quality (STAR) ratings, and a cautious 2026 earnings guide will weigh on near‑term profitability. TD Cowen PT cut
• Negative Sentiment: Humana reported a fourth‑quarter loss and issued a cautious 2026 outlook (management flagged sharply lower near‑term earnings as Medicare Advantage membership surges but margins remain under pressure), which prompted analysts to slash forecasts and is the primary fundamental reason for downward pressure on the stock. Humana stock falls on disappointing earnings forecast

Analyst Upgrades and Downgrades

A number of research firms have commented on HUM. Cantor Fitzgerald lowered their target price on shares of Humana from $290.00 to $201.00 and set a “neutral” rating for the company in a report on Thursday. Truist Financial reduced their price target on Humana from $300.00 to $285.00 and set a “hold” rating on the stock in a research report on Monday, November 10th. TD Cowen decreased their price objective on Humana from $260.00 to $173.00 and set a “hold” rating for the company in a research note on Friday. JPMorgan Chase & Co. dropped their price objective on Humana from $274.00 to $180.00 and set a “neutral” rating for the company in a report on Friday. Finally, Raymond James Financial reduced their target price on Humana from $340.00 to $230.00 and set an “outperform” rating on the stock in a report on Friday. Seven investment analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and five have given a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $238.29.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.